Recombinant full-length human p16INK4A was expressed in E. coli cells using a N-terminal GST tag.
Catalog No. C30-30G
Catalog No. | Pack Size | Price (USD) | |
---|---|---|---|
C30-30G-20 | 20 ug | $215 | |
C30-30G-50 | 50 ug | $435 | |
C30-30G-BULK | BULK | Contact Us |
Overview:
p16INK4A protein family specifically inhibit cyclin-dependent kinase 4-mediated phosphorylation of the retinoblastoma (Rb) susceptibility gene product. p16INK4A, has been identified as a tumor suppressor in many human cancers and inactivation of p16INK4A in tumors is thought to be required in order for many malignant cell types to enter S-phase (1). p16INK4A expression is required for the reduction in cdk4- and cdk6-mediated Rb kinase activity observed in response to DNA damage. p16INK4A gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene (2).
Gene Aliases:
CDKN2A, ARF, MLM, p14, p16, p19, CMM2, INK4, MTS1, TP16, CDK4I, CDKN2, INK4a, p14ARF, p16INK4
Genbank Number:
References:
1. Smith-Sørensen, B. et al: CDKN2A (p16INK4A) somatic and germline mutations. Hum. Mutat. 1996; 7 (4): 294-303.
2. Kusy, S. et al: p14ARF, p15INK4b and p16INK4a methylation status in chronic myelogenous leukemia. Leuk, Lymphoma, 2005; 45 (10): 1989-94.
Purity:
Sample Purity Data. For specific information on a given lot, see related technical data sheet.
Storage, Stability, and Shipping:
Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Molecular Weight:
41 kDa
Cancer, Cell Cycle
STAY CONNECTED
Fax: 1-604-232-4601